![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
|
|
|
|
|
||
Most-read rankings are recalculated at the beginning of the month and are based on full-text and pdf views.
| 1. | Amber L. Pond, Howard W. Chambers, Cody P. Coyne, Janice E. Chambers | ||
|
|
Purification of Two Rat Hepatic Proteins with A-Esterase Activity Toward Chlorpyrifos-Oxon and Paraoxon | |
|---|---|---|---|
|
|
J. Pharmacol. Exp. Ther. Sep 01, 1998; 286: 1404-1411.
(In "ARTICLES") |
|
|
|
||
| 2. | Craig E. Crosson, Phillip W. Yates, Aruna N. Bhat, Yurii V. Mukhin, Shahid Husain | ||
|
|
Evidence for Multiple P2Y Receptors in Trabecular Meshwork Cells | |
|
|
J. Pharmacol. Exp. Ther. May 01, 2004; 309: 484-489.
(In "CELLULAR AND MOLECULAR PHARMACOLOGY") |
|
|
|
||
| 3. | Yoshikazu Fujimori, Kenji Katsuno, Ikumi Nakashima, Yukiko Ishikawa-Takemura, Hideki Fujikura, Masayuki Isaji | ||
|
|
Remogliflozin etabonate, in a Novel Category of Selective Low-Affinity / High-Capacity Sodium Glucose Cotransporter (SGLT2) Inhibitors, Exhibits Antidiabetic Efficacy in Rodent Models | |
|
|
J. Pharmacol. Exp. Ther. Jun 26, 2008; doi: 10.1124/jpet.108.140210.
(In "Endocrine and Diabetes") |
|
|
|
||
| 4. | Darlene C. Deecher, Chad E. Beyer, Grace Johnston, Jenifer Bray, S. Shah, M. Abou-Gharbia, Terrance H. Andree | ||
|
|
Desvenlafaxine Succinate: A New Serotonin and Norepinephrine Reuptake Inhibitor | |
|
|
J. Pharmacol. Exp. Ther. Aug 01, 2006; 318: 657-665.
(In "NEUROPHARMACOLOGY") |
|
|
|
||
| 5. | Theodore A. Slotkin | ||
|
|
Fetal Nicotine or Cocaine Exposure: Which One is Worse? | |
|
|
J. Pharmacol. Exp. Ther. Jun 01, 1998; 285: 931-945.
(In "THE 1998 ASPET OTTO KRAYER AWARD LECTURE") |
|
|
|
||
| 6. | Ronald J. Tallarida | ||
|
|
Drug Synergism: Its Detection and Applications | |
|
|
J. Pharmacol. Exp. Ther. Sep 01, 2001; 298: 865-872.
(In "PERSPECTIVES IN PHARMACOLOGY") |
|
|
|
||
| 7. | Seddigheh Razani-Boroujerdi, Bruce Edwards, Mohan L. Sopori | ||
|
|
Lead Stimulates Lymphocyte Proliferation Through Enhanced T Cell-B Cell Interaction | |
|
|
J. Pharmacol. Exp. Ther. Feb 01, 1999; 288: 714-719.
(In "ARTICLES") |
|
|
|
||
| 8. | Chun-Su Yuan, Gang Wei, Joseph F. Foss, Michael O''Connor, Theodore Karrison, Joachim Osinski | ||
|
|
Effects of Subcutaneous Methylnaltrexone on Morphine-Induced Peripherally Mediated Side Effects: A Double-Blind Randomized Placebo-Controlled Trial | |
|
|
J. Pharmacol. Exp. Ther. Jan 01, 2002; 300: 118-123.
(In "NEUROPHARMACOLOGY") |
|
|
|
||
| 9. | Karl B. Scheidweiler, Mark A. Plessinger, Jalil Shojaie, Ronald W. Wood, Tai C. Kwong | ||
|
|
Pharmacokinetics and Pharmacodynamics of Methylecgonidine, a Crack Cocaine Pyrolyzate | |
|
|
J. Pharmacol. Exp. Ther. Dec 01, 2003; 307: 1179-1187.
(In "TOXICOLOGY") |
|
|
|
||
| 10. | Kenji Katsuno, Yoshikazu Fujimori, Yukiko Takemura, Masahiro Hiratochi, Fumiaki Itoh, Yoshimitsu Komatsu, Hideki Fujikura, Masayuki Isaji | ||
|
|
Sergliflozin, a Novel Selective Inhibitor of Low-Affinity Sodium Glucose Cotransporter (SGLT2), Validates the Critical Role of SGLT2 in Renal Glucose Reabsorption and Modulates Plasma Glucose Level | |
|
|
J. Pharmacol. Exp. Ther. Jan 01, 2007; 320: 323-330.
(In "Endocrine and Diabetes") |
|
|
|
||
| [Next 10 Articles] | |||
= from the current issue
Last Updated: 08/09/2008 07:03:38
 |
 |
 |
|
 |
 |
 |